Author

Michael S. Henson

University of MinnesotaORCID 0000-0001-7187-351XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Aaron L. SarveriD· 1 shared Amber L. Winter· 1 shared Andrea Chehadeh· 1 shared Antonella BorgattiiD· 1 shared Caitlin Preusser· 1 shared Donna M. Groschen· 1 shared Flaviu TăbăraniD· 1 shared G. R. CutteriD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aaron L. SarverORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyMolecular Therapy — OncolyticsPeer-reviewedOct 14, 2023

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma.

Kelly M. Makielski, Aaron L. Sarver, Michael S. Henson…·Shruthi Naik

This study evaluates neoadjuvant oncolytic virus therapy in dogs with osteosarcoma, finding it safe and associated with increased long-term survivorship and immune gene expression.

26 citations

bulk RNA-seqexperimental assay

𝕏 PostBluesky